CG Results Healthcare has advised Novartis on its strategic alliance with BASF

  • Service: Divestments
  • Sector: Healthcare
  • Sub Sector: Pharma & Biotech
  • Engagement Type: Sell Side
May 2021
has formed a strategic alliance with

CG Results Healthcare is delighted to have been the exclusive advisor to leading global medicines company Novartis, on its strategic alliance with BASF, the largest chemical producer in the world, and the first external company to become part of the Novartis Kundl/Schaftenau Life Science Park.

Novartis is further developing its campus in Kundl/Schaftenau by attracting companies from the life sciences sector. An attractive research and production location is being created that benefits from excellent, competitive production conditions in the heart of Europe and the immediate proximity to Switzerland, Italy and Germany.

BASF is the first external company to become part of the Life Science Park and at the same time an important player in the enzyme and biotechnology industry. BASF will invest in a world-scale plant for the production of bacterial enzymes and thus further expand the production of enzymes and biotech products at the site.

This transaction highlights CG Results Healthcare’s excellent sector knowledge and capability in providing advice on strategic options for both healthcare businesses and healthcare assets.

Together with BASF, we plan to sustainably strengthen our site and thus also create additional jobs

Mario Riesner

Managing Director, Novartis Kundl/Shaftnau

Sector Related Deals

May 2022
A subsidiary of Servier
has divested its anti-LAG-3 monoclonal antibody to
A subsidiary of Sino Biopharmaceutical Limited
Mar 2022
has divested its Ringaskiddy, Ireland, manufacturing facility
Mar 2022
has divested its Boucherville, Canada manufacturing facility
Jan 2022
has divested its API manufacturing site in Cramlington, UK, to
Nov 2021
has invested in
company name confidential
Jun 2021
has acquired a drug product manufacturing facility from
Mar 2021
has licensed the patents and know-how to its Crystalomics Formulation Technology to
Jan 2021
has divested its Mirabel manufacturing site in Riom, France to
Jan 2021
has divested its Ringaskiddy analytics and testing site to